PhRMA

Image

SHUTTERSTOCK

Oregon Lawmakers Seek To Curtail Soaring Pharmaceutical Prices

But they face drug industry opposition as they consider bills to make generic drugs more available, limit out-of-pocket insulin costs and set price limits on expensive drugs.

Mar 31, 2021
Premium

Image

SHUTTERSTOCK

First Round of Oregon v. Pharma. State Publishes Data And Stories. Next Up: Trade Secrets

Dec 17, 2019
Premium

Image

PhRMA Files Suit Against Oregon's New Prescription Drug Pricing Laws

Dec 11, 2019

Image

SHUTTERSTOCK

Prescription Drug Price Bill Before Senate

Sep 4, 2019
Premium

Pharma Cash Rolls Into Congress To Defend An Embattled Industry

Aug 27, 2019

PhRMA Lobbying Power Topples the World

Dr. Doug Walta, recently retired chief executive of clinical programs, physician strategy, outreach and diversity for Providence Health & Services painted a bleak picture for Portland State University and Oregon Health Sciences University students preparing for careers in healthcare at a recent Institute for Healthcare Improvement Open School lecture.

Nov 24, 2015

PhRMA Likely to Win Support for Watering Down Prior Authorization of New Drugs

A bill giving the Oregon Health Authority a six-month window before it grants approval without prior authorization to new blockbuster drugs for Medicaid members passed the House unanimously. PhRMA waited until HB 2638 reached the friendly terrain of the Oregon Senate before asking that the bill be gutted.

Jun 2, 2015

PhRMA Fights Six-Month Delay of New Drugs for Medicaid Members

Rep. John Lively has proposed a cost-saving and drug-management measure that would allow the Oregon Health Authority to deny new drugs that have been approved by the FDA in the past six months, while PhRMA is fighting to strip the provision from legislation that passed the House unanimously. The measure does not impact CCOs, which can determine the suitability of most drugs.

Apr 30, 2015

New Report Shows Oregon Clinical Trials Benefit State’s Health and Economy

Working in collaboration with Oregon’s university medical schools, hospitals and clinical research centers, biopharmaceutical companies are conducting or have conducted since 1999 more than 2,300 clinical trials of new medicines in the state, a released today shows.

Feb 15, 2012